Technology
Health
Pharmaceutical

BiondVax Pharmaceuticals

$5.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) Today

Why Robinhood?

You can buy or sell BVXV and other stocks, options, ETFs, and crypto commission-free!

About

BiondVax Pharmaceuticals Ltd. American Depositary Shares, also called BiondVax Pharmaceuticals, is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. Read More It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Ness Ziona, Israel.

Employees
14
Headquarters
Ness Ziona, HaMerkaz
Founded
2003
Market Cap
35.11M
Price-Earnings Ratio
Dividend Yield
Average Volume
6.33K
High Today
Low Today
Open Price
Volume
0.00
52 Week High
$6.93
52 Week Low
$3.51

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
2015 IPO
Asia (Non-China)
Asia

News

MarketBeatFeb 27

Stock Price, News, & Analysis for BIONDVAX PHARMA/S

BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company, focuses on developing and commercializing immunomodulation therapies for infectious diseases primarily in Israel. Its product candidate is M-001, a synthetic peptide-based protein, which has completed Phase II clinical trials that is used for treating seasonal and pandemic strains of the influenza virus. The company was founded in 2003 and is headquartered in Ness Ziona, Israel. MarketBeat Community Rating for BIONDVAX PHARMA/S (NAS...

25

Earnings

-$0.05
-$0.03
-$0.02
$0.00
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.